Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Cash from Operations (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Cash from Operations for 11 consecutive years, with 65456.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Operations rose 107.08% to 65456.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 307264.0, a 289.05% increase, with the full-year FY2024 number at 319718.0, up 93.47% from a year prior.
  • Cash from Operations was 65456.0 for Q3 2025 at KORU Medical Systems, up from 460340.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1336464.0 in Q4 2022 to a low of 4660583.0 in Q1 2023.
  • A 5-year average of 819404.26 and a median of 460340.0 in 2025 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: skyrocketed 286.36% in 2022, then plummeted 4161.23% in 2025.
  • KORU Medical Systems' Cash from Operations stood at 717132.0 in 2021, then surged by 286.36% to 1336464.0 in 2022, then fell by 17.93% to 1096805.0 in 2023, then decreased by 14.33% to 939615.0 in 2024, then crashed by 93.03% to 65456.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Cash from Operations are 65456.0 (Q3 2025), 460340.0 (Q2 2025), and 237467.0 (Q1 2025).